Patents matching “dose”

US 9981092

Pressurised metered dose inhalers and method of manufacture

Cardiff Scintigraphics Limited · Granted May 29, 2018 · Expires May 24, 2038

US 9474728

Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine

TONIX PHARMA LIMITED · Granted Oct 25, 2016 · Expires Oct 20, 2036

US 9463193

Individual 5-fluorouracile dose optimization in folfiri treatment

INSTITUT DE CANCEROLOGIE DE L'OUEST · Granted Oct 11, 2016 · Expires Oct 6, 2036

US 9295659

High dose extended-release potassium citrate wax matrix tablet

UNITED LABORATORIES, INC. · Granted Mar 29, 2016 · Expires Mar 24, 2036

US 9198915

Methods involving aldose reductase inhibitors

The Board of Regents of the University of Texas System · Granted Dec 1, 2015 · Expires Nov 26, 2035

US 9186362

Methods involving aldose reductase inhibitors

The Board of Regents of the University of Texas System · Granted Nov 17, 2015 · Expires Nov 12, 2035

US 8551997

Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use

The Board of Regents of the University of Texas System · Granted Oct 8, 2013 · Expires Oct 3, 2033

US 8450299

Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

Teva Womans's Health, Inc. · Granted May 28, 2013 · Expires May 23, 2033

US 8431615

Dose forms

Vertex Pharmaceuticals Incorporated · Granted Apr 30, 2013 · Expires Apr 25, 2033

US 8415332

Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

Teva Womans's Health, Inc. · Granted Apr 9, 2013 · Expires Apr 4, 2033

US 8288342

Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate

TEVA WOMEN'S HEALTH, INC. · Granted Oct 16, 2012 · Expires Oct 11, 2032

US 8273746

Methods involving aldose reductase inhibitors

The Board of Regents of the University of Texas System · Granted Sep 25, 2012 · Expires Sep 20, 2032

US 7815921

Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy

Ludwig-Maximilians-Universitat Munchen · Granted Oct 19, 2010 · Expires Oct 14, 2030

CA 2739557

PRODUIT PHARMACEUTIQUE POUR AUGMENTER LA DOSE DE VACCIN ANTI-ALLERGIQUE

ALK ABELLO AS [DK] · Granted Apr 22, 2010 · Expires Apr 17, 2030

US 7579006

Method of treating immune pathologies with low dose estrogen

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIR · Granted Aug 25, 2009 · Expires Aug 20, 2029

US 7481212

Increased dosage metered dose inhaler

Nektar Therapeutics · Granted Jan 27, 2009 · Expires Jan 22, 2029

US 7371385

Method of treating immune pathologies with low dose estrogen

Government of the United states of America dba The Department of Veterans Affairs · Granted May 13, 2008 · Expires May 8, 2028

US 6696407

Huntington's disease treatment comprising administering aldose reductase inhibitors to increase striatal CNTF

The Regents of the University of California · Granted Feb 24, 2004 · Expires Feb 19, 2024

US 6692763

Methods for treating postmenopausal women using ultra-low doses of estrogen

The Regents of the University of California · Granted Feb 17, 2004 · Expires Feb 12, 2024

US 6638495

Stabilized preparation for use in metered dose inhalers

Nektar Therapeutics · Granted Oct 28, 2003 · Expires Oct 23, 2023

US 6251362

Method of establishing the optimal radiation dose

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 26, 2001 · Expires Jun 21, 2021

US 6022521

Method of establishing the optimal radiation dose for radiopharmaceutical treatment of disease

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 8, 2000 · Expires Feb 3, 2020